These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2990329)

  • 21. A new antirhinovirus compound, ICI 73602: structure, properties, and spectrum of activity.
    Swallow DL; Bucknall RA; Stanier WE; Hutchinson A; Gaskin H
    Ann N Y Acad Sci; 1977 Mar; 284(1):305-9. PubMed ID: 212977
    [No Abstract]   [Full Text] [Related]  

  • 22. Failure of intranasally administered 4', 6-dichloroflavan to protect against rhinovirus infection in man.
    Al-Nakib W; Willman J; Higgins PG; Tyrrell DA; Shepherd WM; Freestone DS
    Arch Virol; 1987; 92(3-4):255-60. PubMed ID: 3545152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of antirhinovirus activity of 3-hydroxy and 3-methoxy 2-styrylchromones.
    Desideri N; Mastromarino P; Conti C
    Antivir Chem Chemother; 2003 Jul; 14(4):195-203. PubMed ID: 14582848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in rhinovirus therapeutics.
    Charles CH; Yelmene M; Luo GX
    Curr Drug Targets Infect Disord; 2004 Dec; 4(4):331-7. PubMed ID: 15578974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antirhinovirus activity of purine nucleoside analogs.
    De Clercq E; Bernaerts R; Bergstrom DE; Robins MJ; Montgomery JA; Holy A
    Antimicrob Agents Chemother; 1986 Mar; 29(3):482-7. PubMed ID: 3013084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor.
    Zalman LS; Brothers MA; Dragovich PS; Zhou R; Prins TJ; Worland ST; Patick AK
    Antimicrob Agents Chemother; 2000 May; 44(5):1236-41. PubMed ID: 10770757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenicity for humans of human rhinovirus type 2 mutants resistant to or dependent on chalcone Ro 09-0410.
    Yasin SR; al-Nakib W; Tyrrell DA
    Antimicrob Agents Chemother; 1990 Jun; 34(6):963-6. PubMed ID: 2168152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of quantitative correlation between inhibition of replication of rhinoviruses by an antiviral drug and their stabilization.
    Andries K; Dewindt B; Snoeks J; Willebrords R
    Arch Virol; 1989; 106(1-2):51-61. PubMed ID: 2548460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3-Phenylalkyl-2H-chromenes and -chromans as novel rhinovirus infection inhibitors.
    Conti C; Proietti Monaco L; Desideri N
    Bioorg Med Chem; 2017 Apr; 25(7):2074-2083. PubMed ID: 28242170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative test of fifteen compounds against all known human rhinovirus serotypes as a basis for a more rational screening program.
    Andries K; Dewindt B; Snoeks J; Willebrords R; Stokbroekx R; Lewi PJ
    Antiviral Res; 1991 Oct; 16(3):213-25. PubMed ID: 1666824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses.
    Lacroix C; Laconi S; Angius F; Coluccia A; Silvestri R; Pompei R; Neyts J; Leyssen P
    Virol J; 2015 Jul; 12():106. PubMed ID: 26169596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-human rhinovirus 2 activity and mode of action of quercetin-7-glucoside from Lagerstroemia speciosa.
    Song JH; Park KS; Kwon DH; Choi HJ
    J Med Food; 2013 Apr; 16(4):274-9. PubMed ID: 23566054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Four compounds active against rhinovirus: comparison in vitro and in volunteers.
    Reed SE; Craig JW; Tyrrell DA
    J Infect Dis; 1976 Jun; 133 Suppl():A128-35. PubMed ID: 180193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 9-Benzyl-6-(dimethylamino)-9H-purines with antirhinovirus activity.
    Kelley JL; Linn JA; Krochmal MP; Selway JW
    J Med Chem; 1988 Oct; 31(10):2001-4. PubMed ID: 2845083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure of oral 4',6-dichloroflavan to protect against rhinovirus infection in man.
    Phillpotts RJ; Wallace J; Tyrrell DA; Freestone DS; Shepherd WM
    Arch Virol; 1983; 75(1-2):115-21. PubMed ID: 6338868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral effect of hyperthermic treatment in rhinovirus infection.
    Conti C; De Marco A; Mastromarino P; Tomao P; Santoro MG
    Antimicrob Agents Chemother; 1999 Apr; 43(4):822-9. PubMed ID: 10103186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease.
    Patick AK; Brothers MA; Maldonado F; Binford S; Maldonado O; Fuhrman S; Petersen A; Smith GJ; Zalman LS; Burns-Naas LA; Tran JQ
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2267-75. PubMed ID: 15917520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel Series of Highly Potent Small Molecule Inhibitors of Rhinovirus Replication.
    Kim J; Jung YK; Kim C; Shin JS; Scheers E; Lee JY; Han SB; Lee CK; Neyts J; Ha JD; Jung YS
    J Med Chem; 2017 Jul; 60(13):5472-5492. PubMed ID: 28581749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antirhinovirus activity of new 3-benzyl chromene and chroman derivatives.
    Conti C; Desideri N
    Bioorg Med Chem; 2009 May; 17(10):3720-7. PubMed ID: 19398344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative studies on the modes of action of the antirhinovirus agents Ro 09-0410, Ro 09-0179, RMI-15,731, 4',6-dichloroflavan, and enviroxime.
    Ninomiya Y; Aoyama M; Umeda I; Suhara Y; Ishitsuka H
    Antimicrob Agents Chemother; 1985 Apr; 27(4):595-9. PubMed ID: 2988431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.